BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 33516877)

  • 21. The up-regulation of Y-box binding proteins (DNA binding protein A and Y-box binding protein-1) as prognostic markers of hepatocellular carcinoma.
    Yasen M; Kajino K; Kano S; Tobita H; Yamamoto J; Uchiumi T; Kon S; Maeda M; Obulhasim G; Arii S; Hino O
    Clin Cancer Res; 2005 Oct; 11(20):7354-61. PubMed ID: 16243807
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CRIPTO promotes an aggressive tumour phenotype and resistance to treatment in hepatocellular carcinoma.
    Karkampouna S; van der Helm D; Gray PC; Chen L; Klima I; Grosjean J; Burgmans MC; Farina-Sarasqueta A; Snaar-Jagalska EB; Stroka DM; Terracciano L; van Hoek B; Schaapherder AF; Osanto S; Thalmann GN; Verspaget HW; Coenraad MJ; Kruithof-de Julio M
    J Pathol; 2018 Jul; 245(3):297-310. PubMed ID: 29604056
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Oral administration of indole substituted dipyrido[2,3-d]pyrimidine derivative exhibits anti-tumor activity via inhibiting AKT and ERK1/2 on hepatocellular carcinoma.
    Gao X; Cen L; Li F; Wen R; Yan H; Yao H; Zhu S
    Biochem Biophys Res Commun; 2018 Nov; 505(3):761-767. PubMed ID: 30293685
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Unfolded protein response activation contributes to chemoresistance in hepatocellular carcinoma.
    Al-Rawashdeh FY; Scriven P; Cameron IC; Vergani PV; Wyld L
    Eur J Gastroenterol Hepatol; 2010 Sep; 22(9):1099-105. PubMed ID: 20177386
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gefitinib resistance in HCC mahlavu cells: upregulation of CD133 expression, activation of IGF-1R signaling pathway, and enhancement of IGF-1R nuclear translocation.
    Bodzin AS; Wei Z; Hurtt R; Gu T; Doria C
    J Cell Physiol; 2012 Jul; 227(7):2947-52. PubMed ID: 21959795
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association of nuclear YB-1 localization with lung resistance-related protein and epidermal growth factor receptor expression in lung cancer.
    Hyogotani A; Ito K; Yoshida K; Izumi H; Kohno K; Amano J
    Clin Lung Cancer; 2012 Sep; 13(5):375-84. PubMed ID: 22284440
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 2-Methoxyestradiol synergizes with sorafenib to suppress hepatocellular carcinoma by simultaneously dysregulating hypoxia-inducible factor-1 and -2.
    Ma L; Li G; Zhu H; Dong X; Zhao D; Jiang X; Li J; Qiao H; Ni S; Sun X
    Cancer Lett; 2014 Dec; 355(1):96-105. PubMed ID: 25218350
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Macrolide antibiotics differentially influence human HepG2 cytotoxicity and modulate intrinsic/extrinsic apoptotic pathways in rat hepatocellular carcinoma model.
    Abdel-Hamid NI; El-Azab MF; Moustafa YM
    Naunyn Schmiedebergs Arch Pharmacol; 2017 Apr; 390(4):379-395. PubMed ID: 28070612
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Functional Doxorubicin-Loaded Omega-3 Unsaturated Fatty Acids Nanoparticles in Reversing Hepatocellular Carcinoma Multidrug Resistance.
    Wang C; Wei X; Shao G
    Med Sci Monit; 2021 Feb; 27():e927727. PubMed ID: 33524008
    [TBL] [Abstract][Full Text] [Related]  

  • 30. JS-K, a nitric oxide prodrug, induces DNA damage and apoptosis in HBV-positive hepatocellular carcinoma HepG2.2.15 cell.
    Liu Z; Li G; Gou Y; Xiao D; Luo G; Saavedra JE; Liu J; Wang H
    Biomed Pharmacother; 2017 Aug; 92():989-997. PubMed ID: 28605880
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ginkgo biloba Extract Mechanism Inhibits Hepatocellular Carcinoma through the Nuclear Factor-κB/p53 Signaling Pathway.
    Wang R; Shao X; Yang J; Liu Z; Chew L; Shao Y
    J Environ Pathol Toxicol Oncol; 2020; 39(2):179-189. PubMed ID: 32749126
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bevacizumab and CCR2 Inhibitor Nanoparticles Induce Cytotoxicity-Mediated Apoptosis in Doxorubicin-Treated Hepatic and Non-Small Lung Cancer Cells.
    Abd-Rabou AA; Ahmed HH
    Asian Pac J Cancer Prev; 2019 Jul; 20(7):2225-2238. PubMed ID: 31350989
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of the JNK signaling pathway increases sensitivity of hepatocellular carcinoma cells to cisplatin by down-regulating expression of P-glycoprotein.
    Liu XY; Liu SP; Jiang J; Zhang X; Zhang T
    Eur Rev Med Pharmacol Sci; 2016; 20(6):1098-108. PubMed ID: 27049263
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inverse correlation of ribosomal protein S27A and multifunctional protein YB-1 in hepatocellular carcinoma.
    Gunasekaran VP; Ganeshan M
    Clin Biochem; 2014 Sep; 47(13-14):1262-4. PubMed ID: 24833360
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effects of changwelqing on nuclear translocation of Y-box binding protein-1 and expression of P-glycoprotein in human colon cancer cell line with drug-resistance induced by vincristine].
    Xu JH; Deng WL; Fan ZZ
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2010 Jul; 30(7):743-7. PubMed ID: 20929136
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synaptopodin-2 promotes hepatocellular carcinoma metastasis via calcineurin-induced nuclear-cytoplasmic translocation.
    Gao J; Zhang HP; Sun YH; Guo WZ; Li J; Tang HW; Guo DF; Zhang JK; Shi XY; Yu DS; Zhang XD; Wen PH; Shi JH; Zhang SJ
    Cancer Lett; 2020 Jul; 482():8-18. PubMed ID: 32278815
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 17β-estradiol exerts anticancer effects in anoikis-resistant hepatocellular carcinoma cell lines by targeting IL-6/STAT3 signaling.
    Lee S; Lee M; Kim JB; Jo A; Cho EJ; Yu SJ; Lee JH; Yoon JH; Kim YJ
    Biochem Biophys Res Commun; 2016 May; 473(4):1247-1254. PubMed ID: 27091428
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transportin-1-dependent YB-1 nuclear import.
    Mordovkina DA; Kim ER; Buldakov IA; Sorokin AV; Eliseeva IA; Lyabin DN; Ovchinnikov LP
    Biochem Biophys Res Commun; 2016 Nov; 480(4):629-634. PubMed ID: 27794479
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of SIRT1/AMPK axis is critically involved in gallotannin-induced senescence and impaired autophagy leading to cell death in hepatocellular carcinoma cells.
    Kwon HY; Kim JH; Kim B; Srivastava SK; Kim SH
    Arch Toxicol; 2018 Jan; 92(1):241-257. PubMed ID: 28676953
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nuclear translocation of survivin in hepatocellular carcinoma: a key to cancer cell growth?
    Moon WS; Tarnawski AS
    Hum Pathol; 2003 Nov; 34(11):1119-26. PubMed ID: 14652813
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.